💊 Pernicious Anemia Autoimmune Mechanism Simulator

Autoimmune Trigger Onset

Genetic and environmental factors break self-tolerance in the stomach.

• HLA-DR3/4: Genetic Link (placeholder association)
• ~2:1: Female Bias (placeholder ratio)
• >60 yrs: Peak Onset (placeholder age range)
• Thyroiditis: Comorbidity (placeholder overlap)

Loss of self-tolerance

Placeholder: regulatory T-cells fail to suppress autoreactive clones.

Placeholder key insight about tolerance breakdown triggers.

Genetic susceptibility

Placeholder: HLA haplotypes raise autoimmune gastritis risk.

Associated conditions

Placeholder: often co-occurs with other autoimmune endocrine disease.

Parietal Cell Destruction

Cytotoxic T-cells and autoantibodies destroy acid- and IF-producing cells.

• H+/K+ ATPase: Target Antigen (placeholder pump)
• Progressive: Cell Loss (placeholder course)
• CD4+/CD8+: Infiltrate (placeholder lymphocytes)
• Corpus/Fundus: Gland Zone (placeholder location)

Parietal cell antigen target

Placeholder: proton pump autoantigen drives cytotoxic attack.

Placeholder key insight about parietal cell loss mechanism.

Lymphocytic infiltration

Placeholder: gastric mucosa shows dense chronic inflammatory infiltrate.

Progressive cell loss

Placeholder: destruction accumulates silently over years.

Anti-Intrinsic Factor Antibodies

Blocking and binding antibodies neutralize remaining intrinsic factor.

• Blocking IgG: Antibody Type (placeholder class)
• ~50%: Sensitivity (placeholder detection)
• ~95%: Specificity (placeholder detection)
• B12 pocket: Binding Site (placeholder target)

Blocking antibodies

Placeholder: antibodies occupy the B12-binding site of IF.

Placeholder key insight about antibody-mediated IF blockade.

Binding antibodies

Placeholder: a second antibody type prevents ileal receptor binding.

Diagnostic relevance

Placeholder: anti-IF antibodies are a specific diagnostic marker.

Achlorhydria & Gastric Atrophy

The gastric mucosa thins and both acid and IF secretion collapse.

• Near zero: Acid Output (placeholder achlorhydria)
• Elevated: Gastrin Level (placeholder feedback)
• Atrophic: Mucosa (placeholder histology)
• Increased: Cancer Risk (placeholder association)

Achlorhydria

Placeholder: absent acid secretion impairs digestion broadly.

Placeholder key insight about atrophic gastritis progression.

Gastrin feedback loop

Placeholder: low acid drives compensatory hypergastrinemia.

Long-term consequences

Placeholder: chronic atrophy raises gastric neoplasia risk.

B12 Malabsorption & Anemia

Without intrinsic factor, B12 cannot be absorbed and anemia develops.

• Years: B12 Stores (placeholder depletion time)
• Megaloblastic: RBC Type (placeholder morphology)
• Possible: Neuro Signs (placeholder symptom)
• B12 injection: Treatment (placeholder therapy)

B12 absorption pathway

Placeholder: IF-B12 complex is required for ileal uptake.

Placeholder key insight about anemia onset timeline.

Megaloblastic changes

Placeholder: impaired DNA synthesis enlarges red cell precursors.

Clinical management

Placeholder: lifelong B12 replacement bypasses the defect.